T1	Disorder 7 17	arrhythmia
N1 	Reference T1 UMLS:C0003811	arrhythmia
T2	Pharmacological_substance 52 62	cetirizine
N1000 	Reference T2 MeSH:D017332	cetirizine
T3	Disorder 98 117	renal insufficiency
N2 	Reference T3 UMLS:C0035078	renal insufficiency
T6	Disorder 277 296	renal insufficiency
N3 	Reference T6 UMLS:C0035078	renal insufficiency
T7	Pharmacological_substance 317 329	pilsicainide
N1001 	Reference T7 MeSH:C042288	pilsicainide
T9	Pharmacological_substance 406 416	cetirizine
N1002 	Reference T9 MeSH:D017332	cetirizine
T11	Disorder 471 482	bradycardia
N4 	Reference T11 UMLS:C0428977	bradycardia
T12	Pharmacological_substance 649 659	cetirizine
N1003 	Reference T12 MeSH:D017332	cetirizine
T13	Pharmacological_substance 750 760	cetirizine
N1004 	Reference T13 MeSH:D017332	cetirizine
T14	Disorder 801 809	fainting
N5 	Reference T14 UMLS:C0039070	fainting
T15	Pharmacological_substance 946 956	cetirizine
N1005 	Reference T15 MeSH:D017332	cetirizine
T17	Pharmacological_substance 968 980	pilsicainide
N1006 	Reference T17 MeSH:C042288	pilsicainide
T21	Pharmacological_substance 1224 1234	cetirizine
N1007 	Reference T21 MeSH:D017332	cetirizine
T23	Subject 1328 1333	human
T26	Subject 1396 1401	human
T29	Pharmacological_substance 1525 1535	cetirizine
N1008 	Reference T29 MeSH:D017332	cetirizine
T30	Subject 1663 1668	human
T33	Subject 1703 1708	human
T36	Disorder 1797 1807	arrhythmia
N6 	Reference T36 UMLS:C0003811	arrhythmia
T37	Pharmacological_substance 1833 1843	cetirizine
N1009 	Reference T37 MeSH:D017332	cetirizine
T38	Disorder 1875 1886	arrhythmias
N7 	Reference T38 UMLS:C0003811	arrhythmias
T39	Pharmacological_substance 1898 1918	histamine 1 blockers
T40	Disorder 1990 2009	renal insufficiency
N8 	Reference T40 UMLS:C0035078	renal insufficiency
T8	Pharmacological_substance 1539 1551	pilsicainide
N1010 	Reference T8 MeSH:C042288	pilsicainide
T18	Subject 1811 1822	our patient
T22	Pharmacological_substance 2028 2040	pilsicainide
N1011 	Reference T22 MeSH:C042288	pilsicainide
T28	Subject 1293 1308	Xenopus oocytes
T31	Combination 1078 1094	coadministration
T35	Pharmacological_substance 700 712	pilsicainide
N1012 	Reference T35 MeSH:C042288	pilsicainide
T41	Pharmacological_substance 529 541	pilsicainide
N1013 	Reference T41 MeSH:C042288	pilsicainide
T43	Subject 252 271	A 72-year-old woman
T44	Pharmacological_substance 67 79	pilsicainide
N1014 	Reference T44 MeSH:C042288	pilsicainide
T45	Subject 83 92	a patient
T53	Disorder 355 368	feeling faint
N9 	Reference T53 UMLS:C0581879	feeling faint
T54	Disorder 488 496	symptoms
N10 	Reference T54 UMLS:C1457887	symptoms
T58	Disorder 450 465	a wide QRS wave
T62	Combination 623 639	coadministration
T67	Speculation_cue 782 791	suggested
T70	Subject 890 915	6 healthy male volunteers
T71	Pharmacological_substance 1159 1171	pilsicainide
N1015 	Reference T71 MeSH:C042288	pilsicainide
T72	Subject 1976 1984	patients
T78	Manner_cue 1848 1852	less
T79	Speculation_cue 1853 1862	potential
T83	Speculation_cue 1940 1946	should
T4	Combination 376 381	after
